STERIS plc STE
- Market cap
- $20.4B
- P/E
- 25.4×
Follow STE
STERIS plc (STE) Free cash flow
STERIS plc's free cash flow for fiscal 2026 was $982.9M, up 24.9% from $787.2M in fiscal 2025. Over the twelve months to 30 June 2026 it was $936.0M. Over the past ten years it has ranged from $129.1M (fiscal 2016) to $982.9M (fiscal 2026) — the current reading is the highest in ten years. Free cash flow has risen for 4 consecutive fiscal years. STERIS plc ranks 11th of 149 Medical Devices companies by free cash flow.
Free cash flow, annual
Annual
| Period | Free cash flow | Change |
|---|---|---|
| FY2026 | $982.9M | 24.86% |
| FY2025 | $787.2M | 26.89% |
| FY2024 | $620.4M | 51.48% |
| FY2023 | $409.6M | 2.65% |
| FY2022 | $399.0M | (11.52%) |
| FY2021 | $450.9M | 18.61% |
| FY2020 | $380.2M | 6.99% |
| FY2019 | $355.4M | 20.76% |
| FY2018 | $294.3M | 14.93% |
| FY2017 | $256.0M | 98.30% |
Quarterly
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $279.6M | 13.98% |
| Mar 2026 | $245.3M | 16.87% |
| Dec 2025 | $209.9M | 4.32% |
| Sep 2025 | $201.2M | (38.38%) |
| 42 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $2.0B |
| PHG Koninklijke Philips N.V. compare | $1.8B |
| GEHC GE HealthCare Technologies Inc. compare | $1.6B |
| DXCM DexCom, Inc. compare | $1.4B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $1.0B |
| STE STERIS plc | $936.0M |
| BIO Bio-Rad Laboratories, Inc. compare | $353.1M |
| BIO.B Bio-Rad Laboratories, Inc. compare | $353.1M |
| PEN Penumbra, Inc. compare | $215.9M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on STE
- Revenue
- Net income
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement